The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Stemetil 5mg Tablets

Sanofi-Aventis Ireland Limited T/A SANOFIPA0540/127/005

Main Information

Trade NameStemetil 5mg Tablets
Active SubstancesProchlorperazine maleate
Dosage FormTablet
Licence HolderSanofi-Aventis Ireland Limited T/A SANOFI
Licence NumberPA0540/127/005

Group Information

ATC CodeN05AB Phenothiazines with piperazine structure
N05AB04 prochlorperazine


License statusAuthorised
Licence Issued01/04/1977
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back